During the past decade, Hospital Materno Infantil de Málaga conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Materno Infantil de Málaga" #1 sponsor was "Alexion" with 1 trials, followed by "Instituto de Investigación Hospital Universitario La Paz" with 1 trials sponsored, "Intercept Pharmaceuticals" with 1 trials sponsored, "Laboratorios Ordesa" with 1 trials sponsored and "MedImmune LLC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Materno Infantil de Málaga" #1 collaborator was "ALL SCTped Forum" with 1 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Australian & New Zealand Children's Haematology/Oncology Group" with 1 trials as a collaborator and "Dutch Childhood Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Materno Infantil de Málaga" are "Acute Lymphoblastic Leukaemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Biliary Atresia" (1 trials), "Complex Perianal Fistula" (1 trials) and "Congenital Heart Disease" (1 trials). Many other conditions were trialed in "Hospital Materno Infantil de Málaga" in a lesser frequency.

Most popular intervention types in "Hospital Materno Infantil de Málaga" are "Drug" (7 trials), "Biological" (4 trials), "Procedure" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (2 trials), "ALXN1840" (1 trials), "ATG Thymoglobulin" (1 trials), "Busulfan" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Materno Infantil de Málaga" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Materno Infantil de Málaga". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Materno Infantil de Málaga, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Materno Infantil de Málaga, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".